Dorothy Dulko, PhD, on Social Determinants of Developing Colorectal Cancer

Video

During Colorectal Cancer Awareness month, CancerNetwork® sat down with Dorothy Dulko, PhD, to discuss social determinants of cancer.

To continue recognition of Colorectal Cancer Awareness month, CancerNetwork® sat down with Dorothy Dulko, PhD, APRN-C, AOCNP, WHNP-BC, OB/GYN-NP, CCRP, faculty member for Walden University’s Master of Science in Nursing program, to discuss factors that go into determining cancer disparities.

“One of the most important pieces when describing disparities is something called social determinants of health,” Dulko said. “Some of these social determinants [include] how we live, where we are born, where we work, where we play, where we worship, and our age.”

Dulko went on to say that rates of colorectal cancer, as well as lung and cervical cancers, are higher in places like rural Appalachia as compared with urban areas in the same region. And this, as well as other health disparities, are attributable to patient education levels. In addition, patients with more financial support tend to have better outcomes with their disease as compared with their counterparts with less financial support.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences™ Medical World News®, airing daily on all MJH Life Sciences™ channels.

Recent Videos
Combining sotorasib with panitumumab may reduce the burden of disease in patients with KRAS G12C-mutated metastatic colorectal cancer.
Findings from the CodeBreak 300 study have cemented sotorasib/panitumumab as a third-line treatment option for KRAS G12C-mutated colorectal cancer.
Sotorasib plus panitumumab may offer improved survival compared with previously approved treatment options in KRAS G12C-mutated colorectal cancer.
Additional local, regional, or national policy may bolster access to screening for colorectal cancer, according to Aasma Shaukat, MD, MPH.
Additional progression-free survival data from the phase 3 BREAKWATER trial will be presented at future meetings.
Alessio Pigazzi, MD, PhD, FACS, FASCRS, provides advice for upcoming surgeons starting out in the colorectal cancer field.
Alessio Pigazzi, MD, PhD, FACS, FASCRS, discussed how robot-assisted surgery for colorectal cancers has evolved over the past 20 years.
Alessio Pigazzi, MD, PhD, FACS, FASCRS, discussed surgical and medical oncology developments in the colorectal cancer field.
4 KOLs are featured in this panel.
Related Content